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Introduction – The Government has stated its intention to develop the public health role of community pharmacists1,2. Several barriers to increased pharmacy involvement in public health have been identified: the uniprofessional culture that exists within pharmacy, a preoccupation with the health of individuals, an overemphasis of the biomedical model of health during undergraduate education and the overriding commercial interests of the community pharmacy sector3,4.
Aim – To explore the attitudes of Directors of Public Health (DPHs) and Chief Pharmacists (CPs) within Primary Care Organisations (PCOs) on perceived barriers to the development of community pharmacy’s public health function.
Methods – Initial exploratory interviews were conducted with pharmacy and public health “key players”. Data generated were analysed using QSR Nvivo 2.0 software, recurring themes identified and used to inform the design of a more quantitative research instrument. Following MREC and organisational research governance approval, a self-completion questionnaire was piloted and posted (November 2005) to DPHs and CPs (n=627) at 315 PCOs in the UK, with a follow-up to non-responders 3-weeks later. Data were analysed using SPSS v12.0. Final response rate was 48.8% (n=307) (40.4% (n=124) DPHs; 59.6% (n=183) CPs).




Lack of available funding	64.2	70.2	67.8	30.1	23.0	25.9
Time constraints	52.1	73.0	64.5	40.5	26.4	32.1
Pharmacy’s inexperience of the commissioning process	26.8	68.0	51.2	56.1	24.7	37.5
Unsuitable premises	54.9	30.1	40.3	41.8	65.3	55.7
Unwilling to leave ‘comfort zone’ of dispensary	22.1	43.3	34.7	50.0	47.8	48.7
Table 1 Barriers to the development of the public health function of community pharmacists.

Conclusions – DPHs and CPs within PCOs clearly believe that there exist significant barriers to the development of the public health function of community pharmacists. It is notable that attitudes differ significantly between Public Health Directorates and Pharmacy Departments (all of the differences in the above table are statistically significant - 2 test with <0.05). A lack of available funding and constraints on pharmacists’ time were highlighted as “major” barriers. However, both considered that several other aspects of community pharmacy practice provide obstacles to increasing pharmacist involvement in health improving measures including unsuitable premises, inexperience of pharmacists in PCO commissioning processes and a perceived unwillingness of pharmacists to leave the dispensary area. With the impending move to practice-based commissioning, such barriers could severely restrict pharmacy’s ability to contribute fully to improving the health of the nation.
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	The Government intends to develop the public health role of community pharmacists but progress towards this goal has, to date, been limited.
	Directors of Public Health and Chief Pharmacists in UK Primary Care Organisations were surveyed by self-completion postal questionnaire.
	Policy-makers within the NHS perceive several aspects of current pharmacy practice to be barriers to the development of pharmacy’s public health function.
	These barriers will have to be overcome if pharmacy is to reach its full health improving potential.
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